UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
기사
(전체 255건)
제목보기
제목보기
제목+내용
기사보기
Boehringer Ingelheim Korea CEO was forced to resign?
Rumors are circulating i...
Nam Doo-hyun
|
2018-04-06 16:10
기사보기
Pharmaceutical exports jumped 30% in first two months
South Korea’s exports of...
Nam Doo-hyun
|
2018-04-05 15:09
기사보기
Invossa’s encouraging trial results presented in US
Invossa, gene therapy fo...
Nam Doo-hyun
|
2018-03-28 15:05
기사보기
Prescriptions of anticancer drugs surged in January
Prescriptions of antican...
Nam Doo-hyun
|
2018-03-27 14:14
기사보기
Opdivo adds gastric cancer to indications
Bristol-Myers Squibb Kor...
Nam Doo-hyun
|
2018-03-27 11:34
기사보기
Stem cell therapy developers unaffected by Cha Biotech debacle
Shares of biotech firms ...
Nam Doo-hyun
|
2018-03-26 15:58
기사보기
4 drugmakers’ profits turn to losses
Among KOSDAQ-listed phar...
Nam Doo-hyun
|
2018-03-21 11:38
기사보기
Foreigners buy SillaJen, Samsung BioLogics, dump Celltrion
Foreign investors net pu...
Nam Doo-hyun
|
2018-03-20 12:01
기사보기
‘BMS’ Opdivo to lead cancer immunotherapy market’
Cancer immunotherapy Opd...
Nam Doo-hyun
|
2018-03-14 15:16
기사보기
‘Demand for healthcare cloud service rising’
Cloud service providers ...
Nam Doo-hyun
|
2018-03-12 15:03
기사보기
‘Me Too’ movement spreads to pharma sector
Amid the nationwide spre...
Nam Doo-hyun
|
2018-03-08 11:48
기사보기
Will Invossa face rival cell gene therapy?
The pharmaceutical indus...
Nam Doo-hyun
|
2018-03-07 15:00
-
이전
11
12
13
14
15
16
17
18
19
20
다음
-
Back to Top